Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

NCT02106546 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

970

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Non-Small Cell Lung Cancer

Interventions

DRUG: Carboplatin
DRUG: Veliparib
DRUG: Paclitaxel
DRUG: Placebo to veliparib

Sponsor

AbbVie